BRC
LABU icon

Bell Rock Capital’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bell Rock Capital’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3
Closed -$5K – 447
2018
Q3 		$5K Hold
3
– – ﹤0.01% 382
2018
Q2 		$5K Sell
3
-2
-40% -$3.52K ﹤0.01% 399
2018
Q1 		$8K Sell
5
-25
-83% -$46.5K ﹤0.01% 383
2017
Q4 		$47K Sell
30
-59
-66% -$90.3K 0.03% 253
2017
Q3 		$152K Sell
89
-67
-43% -$93K 0.09% 154
2017
Q2 		$197K Buy
156
+82
+111% +$82.7K 0.12% 121
2017
Q1 		$70K Buy
+74
New +$65.9K 0.06% 160

Other funds holding LABU

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
HIS
Harvest Investment Services Oakbrook Terrace, Illinois $547M AUM 64.58% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bell Rock Capital's LABU Position: Q4 2018 in Review

Bell Rock Capital sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q4 2018, closing a stake of 3 shares — an estimated $5K sold.

Bell Rock Capital first reported a position in LABU in Q1 2017 and held it in 7 quarters. The position peaked at $197K in Q2 2017. 30 funds tracked by Wall St. Rank hold LABU as of Q4 2018.

  • Bell Rock Capital reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q4 2018 after selling out during the quarter.
  • Bell Rock Capital sold 3 Direxion Daily S&P Biotech Bull 3X ETF shares in Q4 2018, an estimated $5K.
  • Bell Rock Capital first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2017 and held it in 7 quarters.
  • Bell Rock Capital's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $197K in Q2 2017.
  • 30 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q4 2018.

Based on Bell Rock Capital's 13F filing for Q4 2018, filed 25 Jan 2019.